Evidence map›Paper›PMID 42665870›Full record

ArticleGeriatrics & gerontology international2026

Repeated Gastrointestinal Disease Reporting and Subsequent Multidomain Health Deterioration: Longitudinal Analyses in CHARLS and ELSA.

Ding Peng, Huihong Zhai

Abstract read
In one paragraph

Article in Geriatrics & gerontology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ding PengDepartment of Gastroenterology, Xuanwu Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0003-3614-5538
Huihong ZhaiDepartment of Gastroenterology, Xuanwu Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0002-8452-6311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo examine whether repeated gastrointestinal disease reporting was associated with subsequent multidomain health deterioration and whether the direction of association was consistent across two national aging cohorts.

methodsCHARLS was the primary longitudinal cohort. Participants with at least two gastrointestinal exposure assessments across waves 1-3 were classified as never, intermittent/low, or persistent/high reporting. The primary composite comprised cognitive, ADL, IADL, or depressive-symptom deterioration. Logistic and robust Poisson models were fitted. ELSA provided a cross-cohort consistency analysis using a pre-Wave-1 gastrointestinal disease/medication proxy.

resultsCHARLS included 12 144 participants/5607 events; fully adjusted models included 9555/4523. Adjusted relative risks were 1.10 (95% CI 1.03-1.18) for intermittent/low and 1.06 (1.01-1.11) for persistent/high reporting. In ELSA, the fully adjusted three-level education model included 3286/1752 and yielded an odds ratio of 1.24 (0.97-1.59); the longitudinal-weighted estimate was 1.21 (0.90-1.63). Gastrointestinal exposure produced negligible incremental discrimination in either cohort.

conclusionsRepeated gastrointestinal reporting was associated with a small increase in subsequent deterioration in CHARLS, while ELSA estimates were directionally similar but less precise. Gastrointestinal history may prompt broader geriatric assessment but is not a stand-alone predictor or evidence of causality.

Indexed as

Activities of Daily LivingAgingGastrointestinal DiseasesGeriatric AssessmentAgedAged, 80 and overFemaleHumansLongitudinal StudiesMaleagingCHARLSELSAgastrointestinal diseasemultidomain health deterioration

Identifiers

PMID42665870
PMCPMC13525159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.